rx-10001
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00941018)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- G-protein coupled receptor ChemR23ACTIVATOR
CMKLR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rx-10001
- rx-10001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00941018 | Phase 1 | Jun 1, 2009 | Pharmaceutical Research Associates, Inc. (PRA), Resolvyx Pharmaceuticals, Inc |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2009 |
| Resolvyx Pharmaceuticals, Inc | For profit | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1